Drug intelligence / Profile preview

6-[N-(4-(aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidine

Development stage: Unknown
Modality: Small Molecules

Overview

6-[N-(4-(aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidine is a synthetic small molecule belonging to the class of naphthalene-2-carboxanilides. It has been studied as an experimental compound, but there are no approved indications or clinical trials beyond preclinical research. Its precise mechanism of action and therapeutic targets have not been established in the literature or major drug databases[1][2][3]. The compound is not approved for use in any country and has not advanced into clinical development.

Other names: N-[4-(aminomethyl)phenyl]-6-carbamimidoylnaphthalene-2-carboxamide

Targets

PLAU (uPA)

Beyond the preview

Go deeper on 6-[N-(4-(aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-[N-(4-(aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidine.

Explore the full profile